Navigation Links
HeartWare Presentation at Leerink Swann Global Healthcare Conference to be Webcast
Date:2/8/2013

FRAMINGHAM, Mass. and SYDNEY, Feb. 8, 2013 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Leerink Swann Global Healthcare Conference at 8:30 a.m. Eastern Standard Time on Wednesday, February 13, 2013.  The conference is being held February 13-14 at the Waldorf-Astoria in New York.

A live webcast of the Company's presentation at the conference will be available via a link provided at www.heartware.com.  A replay of the webcast will be available for 90 days at the site after the presentation.

About HeartWare International

HeartWare International develops and manufactures miniaturized implantable heart pumps, or ventricular assist devices, to treat Class IIIB / IV patients suffering from advanced heart failure. The HeartWare® Ventricular Assist System features the HVAD® pump, a small full-support circulatory assist device designed to be implanted next to the heart, avoiding the abdominal surgery generally required to implant competing devices. The HeartWare System is approved in the United States for the intended use as a bridge to cardiac transplantation in patients who are at risk of death from refractory end-stage left ventricular heart failure, and has received CE Marking in the European Union and has been used to treat patients in 27 international countries. The device is also currently the subject of a U.S. clinical trial for destination therapy. For additional information, please visit the Company's website at www.heartware.com.

HeartWare International, Inc. is a member of the Russell 2000® and its securities are publicly traded on The NASDAQ Stock Market and the Australian Securities Exchange.

HEARTWARE, HVAD, MVAD and HeartWare logos are registered trademarks of HeartWare, Inc.

For further information:
Christopher Taylor
HeartWare International, Inc.
Email: ctaylor@heartwareinc.com
Phone: +1 508 739 0864


'/>"/>
SOURCE HeartWare International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. HeartWare Presentation at the Oppenheimer 23rd Annual Healthcare Conference to be Webcast
2. HeartWare Presentation At The 24th Annual Piper Jaffray Healthcare Conference To Be Webcast
3. HeartWare Presentation At The Lazard Capital Markets 9th Annual Healthcare Conference To Be Webcast
4. HeartWare Reports Third Quarter 2012 Results
5. HeartWare Schedules Third Quarter Conference Call And Webcast
6. HeartWare Presentation at the UBS Global Life Sciences Conference to be Webcast
7. HeartWare Presentation At The Canaccord Genuity 32nd Annual Growth Conference To Be Webcast
8. HeartWare Presentation at the 2012 Wedbush PacGrow Lifesciences Management Access Conference to be Webcast
9. HeartWare Reports Second Quarter 2012 Results
10. HeartWare Completes Acquisition Of World Heart Corporation
11. HeartWare Schedules Second Quarter Conference Call And Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... , December 2, 2016 - bioLytical lanza el INSTI ... de la OMS     Continue Reading ... ... , , ... ha anunciado hoy que está expandiendo el lanzamiento de su INSTI HIV Self ...
(Date:12/2/2016)... -- According to the latest market report published ... Endoscope Reprocessors: Single Basin Automated Endoscope Reprocessors Product Type Segment ... 2024 " the global automated endoscope reprocessors market was valued at US$ 740.6 ... CAGR of 7.2% during an eight-year forecast period 2016-2024, to ... ...
(Date:12/2/2016)... -- In the first ever attempt to include phytocannabinoids ... C. sativa, the Hebrew University in Jerusalem, the University ... , the Universita` del Piemonte Orientale and Phytoplant Research ... unified inventory of phytocannabinoids of different botanical origin. ... chemical and structural diversity of phytocannabinoids. As a result ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... December 02, 2016 , ... FlexiSpot, a trusted ... 60-day free trial program for all of the company’s desktop riser products. A ... hassle free experience. , FlexiSpot’s unique desktop risers use an advanced dual gas ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... of two ostomy patients, standing as living proof that attitude and determination can ... diseases and issues that spike around the holidays. This campaign will offer patients ...
(Date:12/2/2016)... Hawaii (PRWEB) , ... December 02, 2016 , ... ... 2016 at the Hyatt Regency Waikiki Beach Resort and Spa in Honolulu, offering ... in the field of pain management. , The demand for supplemental training ...
(Date:12/2/2016)... Aliso Viejo, California (PRWEB) , ... December 02, 2016 , ... ... that will allow FCPX editors to create versatile lower third titles with just a ... , Pro3rd Accents Volume 2 includes 30 lower third animations. Choose from various ...
(Date:12/2/2016)... ... December 02, 2016 , ... ‘Tis the season for giving! Today, 20 ... the National Family Partnership and the Drug Enforcement Administration as part of the National ... the 10 winning schools who decorated their campuses with this year’s Red Ribbon Week ...
Breaking Medicine News(10 mins):